Pacer Advisors, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Pacer Advisors, Inc.
- $35.5 Billion
- Q1 2025
A detailed history of Pacer Advisors, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Pacer Advisors, Inc. holds 496,959 shares of HRMY stock, worth $15.9 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
496,959
Previous 2,279,918
78.2%
Holding current value
$15.9 Million
Previous $78.5 Million
78.98%
% of portfolio
0.05%
Previous 0.19%
Shares
8 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$212 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$187 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$150 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$50.5 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$41.2 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.89B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...